Literature DB >> 1696428

Holter electrocardiogram monitoring in nephrotic patients during methylprednisolone pulse therapy.

S Fujimoto1, H Kondoh, Y Yamamoto, S Hisanaga, K Tanaka.   

Abstract

We assessed the effect of intravenous methylprednisolone pulse therapy (IMPT) on cardiac rhythm and electrolyte metabolism in patients with nephrotic syndrome. A total of 25 patients had valid evaluations with continuous ambulatory electrocardiograms, and 20 of these had simultaneous sodium and potassium clearances. No significant difference of frequency in complex ventricular arrhythmias (Lown's grades 3-5) between the control and the therapy period was observed; however, 4 patients showed complex ventricular arrhythmias including ventricular tachycardia (2 patients) during the course of therapy. Fractional excretion of potassium and serum potassium significantly increased from baseline after IMPT. Complex ventricular arrhythmias, sometimes leading to sudden death, might ensue from IMPT. These dysrhythmias may be related to an abrupt change in potassium reflux from the cell.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1696428     DOI: 10.1159/000168087

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  14 in total

Review 1.  Corticosteroid-induced adverse events in adults: frequency, screening and prevention.

Authors:  Laurence Fardet; Abdulrhaman Kassar; Jean Cabane; Antoine Flahault
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

2.  First report of supraventricular tachycardia after intravenous pulse methylprednisolone therapy, with a brief review of the literature.

Authors:  Rakesh Kumari; S S Uppal
Journal:  Rheumatol Int       Date:  2005-02-23       Impact factor: 2.631

Review 3.  Cardiac disease in chronic obstructive pulmonary disease.

Authors:  Jeremy A Falk; Steven Kadiev; Gerard J Criner; Steven M Scharf; Omar A Minai; Philip Diaz
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 4.  Cardiovascular effects of noncardiovascular drugs.

Authors:  Satish R Raj; C Michael Stein; Pablo J Saavedra; Dan M Roden
Journal:  Circulation       Date:  2009-09-22       Impact factor: 29.690

5.  Atrial flutter versus atrial fibrillation in a general population: differences in comorbidities associated with their respective onset.

Authors:  Ravi K Mareedu; Ihab B Abdalrahman; Kodlipet C Dharmashankar; Juan F Granada; Po-Huang Chyou; Param P Sharma; Peter N Smith; John J Hayes; Robert T Greenlee; Humberto Vidaillet
Journal:  Clin Med Res       Date:  2009-11-17

Review 6.  Drug-induced atrial fibrillation.

Authors:  Yaman Kaakeh; Brian R Overholser; John C Lopshire; James E Tisdale
Journal:  Drugs       Date:  2012-08-20       Impact factor: 9.546

7.  Microphysiological heart-liver body-on-a-chip system with a skin mimic for evaluating topical drug delivery.

Authors:  Camilly P Pires de Mello; Carlos Carmona-Moran; Christopher W McAleer; Julian Perez; Elizabeth A Coln; Christopher J Long; Carlota Oleaga; Anne Riu; Reine Note; Silvia Teissier; Jessica Langer; James J Hickman
Journal:  Lab Chip       Date:  2020-01-23       Impact factor: 6.799

Review 8.  Atrial Fibrillation and Its Association with Endocrine Disorders.

Authors:  Manjari Devidi; Avanija Buddam; Sunil Dacha; D Sudhaker Rao
Journal:  J Atr Fibrillation       Date:  2014-02-28

9.  Acute symptomatic sinus bradycardia in a woman treated with pulse dose steroids for multiple sclerosis: a case report.

Authors:  Amartya Kundu; Timothy P Fitzgibbons
Journal:  J Med Case Rep       Date:  2015-09-24

10.  Three cases of corticosteroid therapy triggering ventricular fibrillation in J-wave syndromes.

Authors:  Naka Sakamoto; Nobuyuki Sato; Masahide Goto; Motoi Kobayashi; Naofumi Takehara; Toshiharu Takeuchi; Ahmed Karim Talib; Eitaro Sugiyama; Akiho Minoshima; Yasuko Tanabe; Kazumi Akasaka; Junichi Kawabe; Yuichiro Kawamura; Atsushi Doi; Naoyuki Hasebe
Journal:  Heart Vessels       Date:  2013-11-27       Impact factor: 2.037

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.